NEO212: A NOVEL TEMOZOLOMIDE-PERILLYL ALCOHOL CONJUGATE EXHIBITS SUPERIOR ACTIVITY AGAINST TEMOZOLOMIDE RESISTANT GLIOMAS AND INTRACRANIAL TRIPLE NEGATIVE BREAST CANCER METASTASIS

BACKGROUND: Although the alkylating agent temozolomide (TMZ) has become the standard of care in the treatment of malignant gliomas, its overall efficacy is still limited by development of drug resistance, limited blood brain barrier (BBB) penetrance, and myelotoxicity. Recently, we have synthesized...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chen, Thomas C., Schonthal, Axel H., Hofman, Florence M., Wang, Weijun, Cho, Heeyon
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2014
Matèries:
abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4144595/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou208.48
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars